Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells, Leukemia, March 2018, Springer Science + Business Media,
DOI: 10.1038/s41375-018-0113-1.
You can read the full text:
Contributors
The following have contributed to this page
